Naltrexone
Mental Disorder
State University of New York - Upstate Medical UniversitySmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 52/ 100
- Competitive Position
- 89/ 100
Competitive context
13 Active assets in the Mental Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Brexpiprazole Otsuka Pharmaceutical Development & Commercialization, Inc. | Phase 3 | BBB |
Provigil Emory University | Phase 4 | BB |
Galantamine Hydrobromide Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 | BB |
Gardasil 9 Vaccine Eunice Dube | Phase 4 | BB |
Hepatitis B Virus Vaccine Eunice Dube | Phase 4 | BB |
View all 34 →
Same molecule, other indications
Naltrexone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →